Organization · Venture Capital
Sanara
Sanara Capital is a health-tech venture capital fund based in Israel, focusing on investments in Digital Health, Bio-Convergence, and Medical Devices. It primarily engages in Series A and B financing rounds for Israeli-related startups.
Overview
What Sanara does
What Sanara is
Sanara Capital is a health-tech venture capital fund based in Israel, focusing on investments in Digital Health, Bio-Convergence, and Medical Devices. It primarily engages in Series A and B financing rounds for Israeli-related startups.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Sanara elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sanara as a funder
Investment thesis
Sanara Capital specializes in health-tech investments, focusing on Digital Health, Bio-Convergence, and Medical Devices. The fund aims to support Israeli-related startups in Series A and B financing rounds, leveraging its strong backing from industry leaders.
Focus narrative
Sanara Capital invests primarily in health-tech sectors, specifically targeting Digital Health, Bio-Convergence, and Medical Devices. The fund supports companies in A and B financing rounds and has a diversified portfolio of nearly 20 companies across both funds, emphasizing operational support alongside capital investment.
Value beyond capital
Sanara Capital offers more than just capital; it provides portfolio companies with access to a vast network of clinical and commercial resources through its partnerships with Philips and Teva. The fund's 100-person global advisory board enhances operational support, helping startups navigate the complexities of the health-tech landscape.
Terms and economics
- Typical check
- $1,000,000
Focus and fit
- Stages
- Series A · Series B
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: NanoDrops: Develops a technology for visual optical correction using a superficial laser imprint combined with eye drops. CVaid Medical: Focuses on advanced diagnostic tools for early stroke detection, utilizing AI-based platforms for stroke triage. Lydus Medical: Innovates in automated microvascular anastomosis for cardiovascular, transplant, and reconstructive microsurgery. QLog: Provides a digital platform aimed at improving operational readiness and workflow efficiency in healthcare facilities.
Common questions
What to know about Sanara
Upseed classifies Sanara under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.